- Latest available (Revised)
- Point in Time (31/12/2020)
- Original (As adopted by EU)
Commission Implementing Regulation (EU) No 564/2013Show full title
Commission Implementing Regulation (EU) No 564/2013 of 18 June 2013 on the fees and charges payable to the European Chemicals Agency pursuant to Regulation (EU) No 528/2012 of the European Parliament and of the Council concerning the making available on the market and use of biocidal products (Text with EEA relevance)
You are here:
- Regulations originating from the EU
- 2013 No. 564
- Annexes only
What Version
Advanced Features
- Show Geographical Extent(e.g. England, Wales, Scotland and Northern Ireland)
- Show Timeline of Changes
More Resources
Revised version PDFs
- Revised 19/11/20140.65 MB
Legislation originating from the EU
When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.
This item of legislation originated from the EU
Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).
Changes over time for: Commission Implementing Regulation (EU) No 564/2013 (Annexes only)
Alternative versions:
Status:
Point in time view as at 31/12/2020.
Changes to legislation:
There are outstanding changes not yet made to Commission Implementing Regulation (EU) No 564/2013. Any changes that have already been made to the legislation appear in the content and are referenced with annotations.
Changes to Legislation
Changes and effects yet to be applied by the editorial team are only applicable when viewing the latest version or prospective version of legislation. They are therefore not accessible when viewing legislation as at a specific point in time. To view the ‘Changes to Legislation’ information for this provision return to the latest version view using the options provided in the ‘What Version’ box above.
ANNEX IU.K.
Fees relating to active substances
| Table 1 | ||
| Standard fees | ||
| General description of task; relevant provision in Regulation (EU) No 528/2012 | Specific condition or task description | Fee (EUR) |
|---|---|---|
| Approval of an active substance; Article 7(2) | Fee for the first product-type for which that active substance is approved | 120 000 |
| Additional fee per additional product-type | 40 000 | |
| Additional fee per product-type (for both the first product-type and any additional product-type) if the active substance is a candidate for substitution in accordance with Article 10 of Regulation (EU) No 528/2012 | 20 000 | |
| Fee for the amendment of an approval, other than the addition of a product-type. | 20 000 | |
| Renewal of an approval; Article 13(3) | Fee for the first product-type for which renewal of that active substance is sought | 15 000 |
| Additional fee per additional product-type | 1 500 | |
| Additional fee for the first product-type for which renewal of that active substance is sought in case a full evaluation is found necessary in accordance with Article 14(1) of Regulation (EU) No 528/2012 | 25 000 | |
| Additional fee per additional product-type in case a full evaluation is found necessary in accordance with Article 14(1) of Regulation (EU) No 528/2012 | 2 500 | |
| Additional fee per product-type (for both the first product-type and any additional product-type) if the active substance is a candidate for substitution in accordance with Article 10 of Regulation (EU) No 528/2012 | 20 000 | |
| Inclusion in Annex I of an active substance; Article 28 | Fee for the first inclusion in Annex I of an active substance | 10 000 |
| Fee for the amendment of an inclusion of an active substance in Annex I | 2 000 | |
| Notification in accordance with Article 3a of Regulation (EC) No 1451/2007 | Fee per substance/product-type combination. The fee for the notification shall be deducted from the subsequent application in accordance with Article 7 of Regulation (EU) No 528/2012. | 10 000 |
| Table 2 | |
| Fee reductions for applications for the approval, renewal of approval, inclusion in Annex I of active substances if the active substance manufacturer is an SME established in the Union, except where the active substance is a candidate for substitution | |
| Type of enterprise | Reduction (% of the standard fee) |
|---|---|
| Micro enterprise | 60 |
| Small enterprise | 40 |
| Medium enterprise | 20 |
ANNEX IIU.K.
Fees for Union authorisation of biocidal products
| Table 1 | ||
| Standard fees | ||
| General description of task; relevant provision in Regulation (EU) No 528/2012 | Specific condition or task description | Fee (EUR) |
|---|---|---|
| Granting of Union authorisation, single product; Article 43(2) | Fee per product not identical with (one of) the representative product(s) assessed for the purpose of the substance approval | 80 000 |
| Fee per product identical with (one of) the representative product(s) assessed for the purpose of the substance approval | 40 000 | |
| Additional fee per product when comparative assessment in accordance with Article 23 of Regulation (EU) No 528/2012 is required | 40 000 | |
| Additional fee per product when the requested authorisation is provisional in accordance with Article 55(2) of Regulation (EU) No 528/2012 | 10 000 | |
| Granting of Union authorisation, biocidal product family; Article 43(2) | Fee per family | 150 000 |
| Additional fee per family when comparative assessment in accordance with Article 23 of Regulation (EU) No 528/2012 is required | 60 000 | |
| Additional fee per family when the requested authorisation is provisional in accordance with Article 55(2) of Regulation (EU) No 528/2012 | 15 000 | |
| Notification to the Agency of an additional product within a biocidal product family; Article 17(6) | Fee per additional product | 2 000 |
| Union authorisation of a same biocidal product; Article 17(7) | Fee per product constituting a ‘same product’ within the meaning of Commission Implementing Regulation (EU) No 414/2013 of 6 May 2013 specifying a procedure for the authorisation of same biocidal products in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Councila | 2 000 |
| Major change of an authorised product or product family; Article 50(2) | Fee per application | 40 000 |
| Minor change of an authorised product or product family; Article 50(2) | Fee per application | 15 000 |
| Administrative change of an authorised product or product family; Article 50(2) | Fee per notification | 2 000 |
| Recommendation on the classification of a change of an authorised product or product family; Article 50(2) | Fee per request in accordance with Regulation (EU) No 354/2013. If the recommendation is to classify the change as an administrative or minor change, the fee for the request shall be deducted from the subsequent application or notification in accordance with Regulation (EU) No 354/2013. | 2 000 |
| Renewal of Union authorisation, single product; Article 45(3) | Fee per product | 5 000 |
| Additional fee per product in case a full evaluation is found necessary in accordance with Article 14(1) of Regulation (EU) No 528/2012 | 15 000 | |
| Additional fee per product when comparative assessment in accordance with Article 23 of Regulation (EU) No 528/2012 is required | 40 000 | |
| Renewal of Union authorisation, biocidal product family; Article 45(3) | Fee per product family | 7 500 |
| Additional fee per product family in case a full evaluation is found necessary in accordance with Article 14(1) of Regulation (EU) No 528/2012 | 22 500 | |
| Additional fee per product family when comparative assessment in accordance with Article 23 of Regulation (EU) No 528/2012 is required | 60 000 | |
| Table 2 | |
| Fee reductions for applications for the granting and renewal of Union authorisation of biocidal products or biocidal product families, if the prospective authorisation holder is an SME established in the Union, except where the product contains an active substance which is a candidate for substitution | |
| Type of enterprise | Reduction (% of the standard fee) |
|---|---|
| Micro enterprise | 30 |
| Small enterprise | 20 |
| Medium enterprise | 10 |
ANNEX IIIU.K.
Other fees
| General description of task; relevant provision in Regulation (EU) No 528/2012) | Specific condition or task description | Fee (EUR) |
|---|---|---|
| Technical equivalence; Article 54(3) | Fee, when difference between the active substance sources is limited to a change in manufacturing location, and application is based solely on analytical data | 5 000 |
| Fee, when difference between the active substance sources goes beyond a change in the manufacturing location, and application is based solely on analytical data | 20 000 | |
| Fee when previous conditions are not met. | 40 000 | |
| Annual fee for biocidal products authorised by the Union; Article 80(1)(a) | Fee per Union authorisation of a biocidal product | 10 000 |
| Fee per Union authorisation of a biocidal product family | 20 000 | |
| Mutual Recognition Submission fee; Article 80(1)(a) | Fee per product or product family concerned by an application for mutual recognition, per Member State where mutual recognition is sought | 700 |
| Appeal; Article 77(1) | Fee per appeal | 2 500 |
| Submission for inclusion in the list of relevant persons; Article 95 | Fee per submission of a letter of access to a dossier already found complete by the Agency or an evaluating Competent Authority | 2 000 |
| Fee per submission of a letter of access to part of a dossier already found complete by the Agency or an evaluating Competent Authority, together with complementary data | 20 000 | |
| Fee per submission of a new dossier | 40 000 | |
| Requests under Article 66(4) submitted to the Agency | Fee per item for which confidentiality is requested | 1 000 |
Options/Help
Print Options
PrintThe Whole Regulation
PrintThe Annexes only
Legislation is available in different versions:
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
See additional information alongside the content
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Opening Options
Different options to open legislation in order to view more content on screen at once
More Resources
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
- the original print PDF of the as adopted version that was used for the EU Official Journal
- lists of changes made by and/or affecting this legislation item
- all formats of all associated documents
- correction slips
- links to related legislation and further information resources
Timeline of Changes
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
More Resources
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
- the original print PDF of the as adopted version that was used for the print copy
- correction slips
Click 'View More' or select 'More Resources' tab for additional information including:
- lists of changes made by and/or affecting this legislation item
- confers power and blanket amendment details
- all formats of all associated documents
- links to related legislation and further information resources
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.